Search Results

You are looking at 1 - 10 of 13 items for :

  • "unknown primary site" x
Clear All
Full access

Donald A. Podoloff

Broussolle C . The role of 2-deoxy-2-[F-18] fluoro-D-glucose positron emission tomography in disseminated carcinoma of unknown primary site . Cancer 2007 ; 109 : 292 – 299 . 17 Alberini JL Belhocine T Hustinx R . Whole-body positron emission

Full access

F. Anthony Greco

The author has no financial interest, arrangement, or affiliation with the manufacturers of any products discussed in the article or their competitors. References 1. Greco FA Hainsworth JD . Cancer of unknown primary site

Full access

Chad E. Galer and Merrill S. Kies

in neck nodes with unknown primary site: role of mucosal radiotherapy . Head Neck 1990 ; 12 : 463 – 469 . 54. Maulard C Housset M Brunel P . Postoperative radiation therapy for cervical lymph node metastases from an occult squamous cell

Full access

David S. Ettinger, Mark Agulnik, Justin M. M. Cates, Mihaela Cristea, Crystal S. Denlinger, Keith D. Eaton, Panagiotis M. Fidias, David Gierada, Jon P. Gockerman, Charles R. Handorf, Renuka Iyer, Renato Lenzi, John Phay, Asif Rashid, Leonard Saltz, Lawrence N. Shulman, Jeffrey B. Smerage, Gauri R. Varadhachary, Jonathan S. Zager and Weining (Ken) Zhen

unknown primary site are uncommon and their clinical behavior is dependent on the tumor grade and differentiation. 80 Neuroendocrine tumors, regardless of grade, represent a favorable prognostic subset of occult primary tumors that are responsive to

Full access

Gauri R. Varadhachary

, treatment and follow-up of cancers of unknown primary site (CUP) . Ann Oncol 2005 ; 16 ( Suppl 1 ): i75 – 76 . 3 Varadhachary GR Abbruzzese JL Lenzi R . Diagnostic strategies for unknown primary cancer . Cancer 2004 ; 100 : 1776 – 1785

Full access

Tilmann Bochtler, Volker Endris, Anna Reiling, Jonas Leichsenring, Michal R. Schweiger, Sebastian Klein, Fabian Stögbauer, Benjamin Goeppert, Peter Schirmacher, Alwin Krämer and Albrecht Stenzinger

.S.). References 1. Varadhachary GR Raber MN . Carcinoma of unknown primary site . N Engl J Med 2014 ; 371 : 2040 . 2. Tothill RW Li J Mileshkin L . Massively-parallel sequencing assists the diagnosis and guided treatment of cancers of

Full access

David S. Ettinger, Charles R. Handorf, Mark Agulnik, Daniel W. Bowles, Justin M. Cates, Mihaela Cristea, Efrat Dotan, Keith D. Eaton, Panagiotis M. Fidias, David Gierada, G. Weldon Gilcrease, Kelly Godby, Renuka Iyer, Renato Lenzi, John Phay, Asif Rashid, Leonard Saltz, Richard B. Schwab, Lawrence N. Shulman, Jeffrey B. Smerage, Marvaretta M. Stevenson, Gauri R. Varadhachary, Jonathan S. Zager, Weining (Ken) Zhen, Mary Anne Bergman and Deborah A. Freedman-Cass

approach. References 1. Greco FA Hainsworth JD . Cancer of unknown primary site . In: DeVita VT Lawrence TS Rosenburg SA , eds. DeBita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology . Vol. 2 . 8th ed. Philadelphia

Full access

Andrew W. Hahn, Smith Giri, Dilan Patel, Heather Sluder, Ari Vanderwalde and Mike G. Martin

relapse . Cancer 1989 ; 64 : 2448 – 2458 . 13. Ross JS Wang K Gay L . Comprehensive genomic profiling of carcinoma of unknown primary site: new routes to targeted therapies . JAMA Oncol 2015 ; 1 : 40 – 49 . 14. Bao R Huang L

Full access

Jennifer Shih, Babar Bashir, Karen S. Gustafson, Mark Andrake, Roland L. Dunbrack, Lori J. Goldstein and Yanis Boumber

profiling . Clin Cancer Res 2013 ; 19 : 4027 – 4033 . 16. Varadhachary GR Raber MN . Cancer of unknown primary site . N Engl J Med 2014 ; 371 : 757 – 765 . 17. Ettinger DS Handorf CR Agulnik M . Occult primary, version 3

Full access

Daniel B. Martin, Sean Silas, Audrey Covner, Paul C. Hendrie and F. Marc Stewart

card for metastatic disease of unknown primary site. There is an index for each diagnosis that includes a disease code and page number. Development of Comorbidity Cards Another challenge of ICD-10 coversion for hematology/oncology providers is